1997
DOI: 10.1016/s0165-2478(97)87987-4
|View full text |Cite
|
Sign up to set email alerts
|

Somatostatin receptor expression in clinical immunology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2008
2008
2008
2008

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Many benign and malignant tumours over express SS-R in their membranes especially in neuroendocrine tumours (NETs) but there are other benign conditions showing an increase number of SSRs, such as granulomatous or inflammatory disease [2] . Octeotride is an analogue whose molecule is a shortened version of somatostatin's, from 8 to 14 aminoacides, sharing its active nuclei and allowing the 111 Indium-DPTA molecule to bind to the N-terminal (d-phe).…”
Section: Introductionmentioning
confidence: 99%
“…Many benign and malignant tumours over express SS-R in their membranes especially in neuroendocrine tumours (NETs) but there are other benign conditions showing an increase number of SSRs, such as granulomatous or inflammatory disease [2] . Octeotride is an analogue whose molecule is a shortened version of somatostatin's, from 8 to 14 aminoacides, sharing its active nuclei and allowing the 111 Indium-DPTA molecule to bind to the N-terminal (d-phe).…”
Section: Introductionmentioning
confidence: 99%